Application of toxicokinetics to improve chemical risk assessment

implications for the use of animals

S Creton, R Billington, W Davies, M P Dent, G M Hawksworth, S Parry, K Z Travis

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

While toxicokinetics has become an integral part of pharmaceutical safety assessment over the last two decades, its use in the chemical industry is relatively new. However, it is recognised as a potentially important tool in human health risk assessment and recent initiatives have advocated greater application of toxicokinetics as part of an improved assessment strategy for crop protection chemicals that could offer greater efficiency, use fewer animals and provide better data for risk assessment purposes. To explore the potential scientific and animal welfare benefits of increased use of toxicokinetic data across the chemical industry, an international workshop was held in 2008. Experts from a wide range of chemical industry sectors, including industrial chemicals, agrochemicals and consumer products, participated in the meeting as well as representatives from relevant regulatory authorities. Pharmaceutical industry experts were also invited, in order to share experiences from the extensive use of toxicokinetics in drug development. Given that increased generation of toxicokinetic data could potentially result in an increased number of animals undergoing testing, technologies and strategies to reduce and refine animal use for this purpose were also considered. This paper outlines and expands upon the key themes that emerged from the workshop.
Original languageEnglish
Pages (from-to)291-299
Number of pages9
JournalRegulatory Toxicology and Pharmacology
Volume55
Issue number3
Early online date7 Aug 2009
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Risk assessment
Animals
Chemical Industry
Chemical industry
Pharmaceutical Preparations
Agrochemicals
Industrial chemicals
Consumer products
Health risks
Education
Animal Welfare
Crops
Drug Industry
Toxicokinetics
Testing
Technology
Safety
Health
Industry

Keywords

  • ADME
  • toxicokinetics
  • dose selection
  • blood sampling
  • 3Rs
  • risk assessment

Cite this

Creton, S., Billington, R., Davies, W., Dent, M. P., Hawksworth, G. M., Parry, S., & Travis, K. Z. (2009). Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals. Regulatory Toxicology and Pharmacology, 55(3), 291-299. https://doi.org/10.1016/j.yrtph.2009.08.001

Application of toxicokinetics to improve chemical risk assessment : implications for the use of animals. / Creton, S; Billington, R; Davies, W; Dent, M P; Hawksworth, G M; Parry, S; Travis, K Z.

In: Regulatory Toxicology and Pharmacology, Vol. 55, No. 3, 12.2009, p. 291-299.

Research output: Contribution to journalArticle

Creton, S, Billington, R, Davies, W, Dent, MP, Hawksworth, GM, Parry, S & Travis, KZ 2009, 'Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals', Regulatory Toxicology and Pharmacology, vol. 55, no. 3, pp. 291-299. https://doi.org/10.1016/j.yrtph.2009.08.001
Creton, S ; Billington, R ; Davies, W ; Dent, M P ; Hawksworth, G M ; Parry, S ; Travis, K Z. / Application of toxicokinetics to improve chemical risk assessment : implications for the use of animals. In: Regulatory Toxicology and Pharmacology. 2009 ; Vol. 55, No. 3. pp. 291-299.
@article{70fe6b1b30724e2d86a324e66a759ac1,
title = "Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals",
abstract = "While toxicokinetics has become an integral part of pharmaceutical safety assessment over the last two decades, its use in the chemical industry is relatively new. However, it is recognised as a potentially important tool in human health risk assessment and recent initiatives have advocated greater application of toxicokinetics as part of an improved assessment strategy for crop protection chemicals that could offer greater efficiency, use fewer animals and provide better data for risk assessment purposes. To explore the potential scientific and animal welfare benefits of increased use of toxicokinetic data across the chemical industry, an international workshop was held in 2008. Experts from a wide range of chemical industry sectors, including industrial chemicals, agrochemicals and consumer products, participated in the meeting as well as representatives from relevant regulatory authorities. Pharmaceutical industry experts were also invited, in order to share experiences from the extensive use of toxicokinetics in drug development. Given that increased generation of toxicokinetic data could potentially result in an increased number of animals undergoing testing, technologies and strategies to reduce and refine animal use for this purpose were also considered. This paper outlines and expands upon the key themes that emerged from the workshop.",
keywords = "ADME, toxicokinetics, dose selection, blood sampling, 3Rs, risk assessment",
author = "S Creton and R Billington and W Davies and Dent, {M P} and Hawksworth, {G M} and S Parry and Travis, {K Z}",
year = "2009",
month = "12",
doi = "10.1016/j.yrtph.2009.08.001",
language = "English",
volume = "55",
pages = "291--299",
journal = "Regulatory Toxicology and Pharmacology",
issn = "0273-2300",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Application of toxicokinetics to improve chemical risk assessment

T2 - implications for the use of animals

AU - Creton, S

AU - Billington, R

AU - Davies, W

AU - Dent, M P

AU - Hawksworth, G M

AU - Parry, S

AU - Travis, K Z

PY - 2009/12

Y1 - 2009/12

N2 - While toxicokinetics has become an integral part of pharmaceutical safety assessment over the last two decades, its use in the chemical industry is relatively new. However, it is recognised as a potentially important tool in human health risk assessment and recent initiatives have advocated greater application of toxicokinetics as part of an improved assessment strategy for crop protection chemicals that could offer greater efficiency, use fewer animals and provide better data for risk assessment purposes. To explore the potential scientific and animal welfare benefits of increased use of toxicokinetic data across the chemical industry, an international workshop was held in 2008. Experts from a wide range of chemical industry sectors, including industrial chemicals, agrochemicals and consumer products, participated in the meeting as well as representatives from relevant regulatory authorities. Pharmaceutical industry experts were also invited, in order to share experiences from the extensive use of toxicokinetics in drug development. Given that increased generation of toxicokinetic data could potentially result in an increased number of animals undergoing testing, technologies and strategies to reduce and refine animal use for this purpose were also considered. This paper outlines and expands upon the key themes that emerged from the workshop.

AB - While toxicokinetics has become an integral part of pharmaceutical safety assessment over the last two decades, its use in the chemical industry is relatively new. However, it is recognised as a potentially important tool in human health risk assessment and recent initiatives have advocated greater application of toxicokinetics as part of an improved assessment strategy for crop protection chemicals that could offer greater efficiency, use fewer animals and provide better data for risk assessment purposes. To explore the potential scientific and animal welfare benefits of increased use of toxicokinetic data across the chemical industry, an international workshop was held in 2008. Experts from a wide range of chemical industry sectors, including industrial chemicals, agrochemicals and consumer products, participated in the meeting as well as representatives from relevant regulatory authorities. Pharmaceutical industry experts were also invited, in order to share experiences from the extensive use of toxicokinetics in drug development. Given that increased generation of toxicokinetic data could potentially result in an increased number of animals undergoing testing, technologies and strategies to reduce and refine animal use for this purpose were also considered. This paper outlines and expands upon the key themes that emerged from the workshop.

KW - ADME

KW - toxicokinetics

KW - dose selection

KW - blood sampling

KW - 3Rs

KW - risk assessment

U2 - 10.1016/j.yrtph.2009.08.001

DO - 10.1016/j.yrtph.2009.08.001

M3 - Article

VL - 55

SP - 291

EP - 299

JO - Regulatory Toxicology and Pharmacology

JF - Regulatory Toxicology and Pharmacology

SN - 0273-2300

IS - 3

ER -